Medicinal plants and memory

Indian Drugs

Volumn 40, Issue 6, 2003, Pages 313-319

  Dhingra, D ^c   Parle, M ^a   Kulkarni, S K ^b  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b PANJAB UNIVERSITY   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ARECOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; GINSENG EXTRACT; MENTAL; MUSCARINIC AGENT; NICOTINIC AGENT; PILOCARPINE; PLANT EXTRACT; SALVIA LAVANDULAEFOLIA EXTRACT; SALVIA OFFICINALIS EXTRACT; SAPONIN; UNCLASSIFIED DRUG; WITHANIA SOMNIFERA EXTRACT;

ALZHEIMER DISEASE; AMNESIA; BRAIN; CHOLINERGIC ACTIVITY; COGNITIVE DEFECT; DEMENTIA; DISEASE MODEL; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL ANIMAL; HIPPOCAMPUS; HUMAN; LEARNING; MEDICINAL PLANT; MEMORY; NONHUMAN; NUTRITION; PHYSICIAN; POPULATION RESEARCH; PREVALENCE; REVIEW; SALVIA; SALVIA LAVANDULAEFOLIA; SKILL;

EID: 11144336040     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Vas C.J., Pinto C., Panikker D., Noronha S. Prevalence of dementia in an urban Indian population, Int. Psychogeriatr. 2001, 13 (4), 389-93.
2. Lopes M.A. and Bottino C.M: Prevalence of dementia in several regions of the world: analysis of epidemiological studies from 1994 to 2000, Arq. Neuropsiquiatr. 2002, 60(1), 61-69.
3. Bhattacharya S.K., Kumar A. and Jaiswal A.K: Effect of Mentat®, a herbal formulation, on experimental models of Alzheimer's disease and central cholinergic markers in rats, Fitoterapia 1995, 66, 216-222.
4. Bhattacharya S.K. and Kumar A: Effect of Trasina®, an ayurvedic herbal formulation, on experimental models of Alzheimer's disease and central cholinergic markers in rats, J. Altern. Complement. Med. 1997, 3(4), 327-36.
5. Nishiyama N., Moriguchi T., Morihara N. and Saito H: Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-acclerated mice, J. Nutr. 2001, 131(3s), 109s-105s.
6. Park C.H., Kim S.H., Choi W., Lee Y.J., Kim J.S., King S., Suh Y.H: Novel anticholinesterase and antiamnesic activities of dehydro-evodiamine, a constituent of Evodia rufaecarpa, Planta Medica 1996, 62, 405-409.
7. Perry N., Court G., Bidet N., Courk J. and Perry E: European herbs with cholinergic activities: Potential in dementia therapy, Int. J. Geriatric Psychiatry, 1996, 11, 1063-69.
8. Singh H.K. and Dhawan B.N: Effect of Bacopa monniera (Brahmi) extract on avoidance responses in rats, J. Ethnopharmacol. 1982, 5, 205-14.
9. Singh H.K., Rastogi R.P., Srimal R.C. and Dhawan B.N: Effect of Bacosides A and B on avoidance responses in rats, Phytother. Res., 1988, 2, 70-75.
10. Singh H.K. and Dhawan B.N: Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn (Brahmi), Ind. J. Pharmacol., 1997, 29, S 359-65.
11. Kidd P.M: A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med. Rev. 1999, 41(3), 144-161.
12. Tripathi Y.B., Chaurasia S., Tripathi E., Upadhyay A. and Dubey G.P: Bacopa monniera Linn. as an antioxidant: mechanism of action, Indian J. Exp. Biol. 1996, 34(6), 523-526.
13. Vohora D., Pal S.N. and Pillai K.K: Protection from phenytoin induced cognitive defict by Bacopa monniera, a reputed Indian nootropic plant, J. Ethnopharmacology 2000, 71(3), 383-390.
14. Stough C., Lloyd J., Clarke J., Downey L.A., Hutchison C.W., Rodgers T. and Nathan P.J: The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects, Psychopharmacology 2001, (Berl), 156(4), 481-4.
15. Negi K.S., Singh, Y.D., Kushwaha K.P., Rastogi C.K., Rathi, A.K., Srivastava J.S, Asthana O.P. and Gupta R.C: Clinical evaluation of memory enhancing properties of Memory Plus in children with Attention Deficit Hyperactivity Disorder, Ind. J. Psychiat. 2000, 42 (Suppl), 27.
16. Srivastava J.S., Asthana O.P., Gupta R.C., Negi K.S., Jauhari N., Singh Y.D., Kushwaha K.P., Rastogi C.K. and Rathi A. K: Double blind placebo controlled randomized study of standardized Bacopa monniera extract in children with Attention Deficit Hyperactivity Disorder, Ind. J. Psychiat. 2002, 44 (Suppl), 28.
17. Gattu M., Boss K.L., Terry A.V. and Buccafusco J.L: Reversal of scopolamine-induced deficits in navigational memory performance by the seed oil of Celastrus paniculatis, Pharmacol. Biochem. Behav. 1996, 57(4), 793-799.
18. Kim S.R., Hwang S.Y., Jang Y.P., Park M.J., Markelonis G.J., Oh. T.H. and Kim Y.C: Protropine from Corydalis ternata has anticholinesterase and antiamnesic activities, Planta. Med. 1999, 65(3), 218-21.
19. Fulton B.& Benfield P: Galanthamine, Drugs and Aging 1996, 9, 60-65.
20. Barnes C.A., Meltzer J., Houston F., Orr G., McGann K. and Wenk G.L: Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors, Neuroscience 2000, 99(1), 17-23.
21. Taylor J.E: Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract, Presse Medicale-Paris 1986, 15, 491-493.
22. Smith P.F., MacLennan K. and Darlington C.L: The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor, J. Ethnopharmacol 1996, 56, 131-139.
23. Bruno C., Cuppini R., Sartini S., Cecchini T., Ambrogini P. and Bombardelli E: Regeneration of motor nerves in bilobalide-treated rats, Planta Medica 1998, 59, 302-307.
24. Eikelenboom P: Inflammation et maladied' Alzheimer, Alzheimer Actual. 1996, 107, 8-12.
25. DeFeudis F.V: Ginkgo biloba extract (EGb 761): from chemistry to the clinic, Publr Ullstein Med. Weisbaden, Germany, 1998.
26. Wirth S., Stemmelin J., Will B., Christen YVES, and Di Scala G: Facilitative effects of EGb 761 on olfactory recognition in young and aged rats, Pharmacol Biochem Behav. 2000, 65(2), 321-6.
27. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M. and Schatzberg A.F: A placebo-controlled, double-blind randomized trial of an extract of Ginkgo biloba for dementia, J. Amer. Med. Assoc. 1997, 278, 1327-32.
28. LeBars P.L. and Kastelan J: Efficacy and Safety of a Ginkgo biloba extract, Public Health Nutr. 2000, 3(4A), 495-9.
29. Mix J.A. and Crews W.D. Jr: An examination of the efficacy of Ginkgo biloba extract EGb 761 on the neuropsychologic functioning of cognitively intact older adults, J. Altern Complement Med. 2000, 6(3), 219-29.
30. Vesper J. and Hansgen K.D: Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age, Phytomedicine. 1994, 1, 9-16.
31. Moulton P.L., Boyko L.N., Fitzpatrick J.L. and Petros T.V: The effect of Ginkgo biloba on memory in healthy male volunteers, Physiol. Behav. 2001, 73(4), 659-65.
32. Rigney U., Kimber S. and Hindmarch I: The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers, Phytother Res. 1999, 13(5), 408-15.
33. Stough C., Clarke J., Lloyd J. and Nathan P.J: Neuropsychological changes after 30-days Ginkgo biloba administration in healthy participants, Int. J. Neuropsychopharmacol 2001, 4 (2), 131-4.
34. Cheng D.J., Ren H. and Tang X.C: Huperzine A: a novel promising acetyl cholinesterase inhibitor, Neuroreport 1996, 8, 97-101.
35. Bai D.L., Tang X.C. and He X.C: Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease, Curr. Med. Chem. 2000, 7(3), 355-374.
36. Ye J.W., Shang Y.Z., Wang Z.M. and Tang X.C: Huperzine A ameliorates the impaired memory of aged rat in the Morris water maze performance, Acta Pharmacol Sin. 2000, 21(1), 65-69.
37. Khalifa A.E: Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice, J. Ethanopharmacol 2001, 76(1), 49-57.
38. Mitchell S: Aromatherapy's effectiveness in disorders associated with dementia, Int. J. Aromatherapy 1993, 5, 20-23.
39. Lee P.N: Smoking and Alzheimer's disease: a review of the epidemioiogical evidence, Neuroepidemiology 1994, 13, 131-144.
40. Brown R.W., Gonzalez C.L. and Kolb B: Nicotine improves Morris water task performance in rats given medial frontal cortex lesions, Pharmacol. Biochem. Behav. 2000, 69(3), 473-8.
41. Ernst M., Heishman S.J., Spurgeon L. and London E.D: Smoking history and nicotine effects on cognitive performance, Neuropsychopharmacology 2001, 25(3), 319-9.
42. Ohta H., Ni J.W., Matsumoto K., Watanabe H. and Shimizu M: Paeony and its major constituent, Paeoniflorin improve radial maze performance impaired by scopolamine in rats, Pharmacol. Biochem. Behav. 1993, 45, 719-23.
43. Hirokawa S., Nose M., Ishige A., Amagaya S., Oyama T. and Ogihara Y: Effect of Hachimi-jio-gan on scopolamine-induced memory impairment and on acetylcholine content in rat brain, J. Ethnopharmacol 1996, 50, 77-84.
44. Vohra B.P. and Hui X: Improvement of impaired memory in mice by taurine, Neural Plant 2000, 7(4), 245-59.
45. Mann J: Murder, magic and medicine, Oxford University Press, 1992.
46. Fan W., Tezuka Y., Ni K.M. and Kadota S: Prolylendopeptidase inhibitors from the underground part of Rhodiola sachalinensis, Chem Pharm. Bull (Tokyo) 2001, 49(4), 396-401.
47. Darbinyan V., Kteyan A., Panossian A., Gabrielian E., Wikman G., and Wagner H: Rhodiola rosea in stress induced fatigue- a double blind cross-over study of a standardized extract SHR-5 with a repeated low dose regimen on the mental performance of healthy physicians during night duty, Phytomedicine 2000, 7(5), 365-71.
48. Ferraz A.C., Angelucci M.E., Da Costa M.L., Batista I.R., Deoliveira B.H. and DaCunha C: Pharmacological evaluation of ricinine, a CNS stimulant isolated from Ricinus communis, Pharmacol. Biochem. Behav. 1999, 63(3), 367-75.
49. Le Strange R: A History of Herbal Plants, Morrison and Gibb, London 1997.
50. Price S. and Price L: Aromatherapy for Health Professionals, Churchill Livingstone, Edinburgh 1995.
51. Schliebs R., Liebmann A., Bhattacharya S.K., Kumar A., Ghosal S. and Bigi V: Systemic administration of defined extracts of Withania somnifera (Indian ginseng) and Shilajit differentially affects cholinergic but not glutametergic and GABAergic markers in rat brain, Neurochemistry Interntional. 1997, 30, 181-190.
52. Reid D.P: Chinese Herbal Medicine, Shambala Publications, Massachusetts 1986.
53. Nitta H., Matsumoto K., Shimiza M., Nix X.H., Watanabe H: Panax ginseng extract improves the scopolamine-induced disruption of 8-arm radial maze performance in rats, Pharmaceut. Bull. 1995, 18, 1439.
54. Lim J.H., Wen T.C., Matsuda S., Tanaka J., Maeda N., Peng H., Aburaya J., Fushihara K. and Sanaka M: Protection of ischemic neurons by ginsenoside Rbl, a main ingredient of ginseng root, Neurosci. Res. 1997, 28, 191-200.
55. Jin S.H., Park J.K., Nam K.Y., Park S.N. and Jung N.P: Korean red ginseng saponins with low ratios of protopanaxadiol and protopanaxatriol saponin improve scopolamine-induced learning disability and spatial working memory in mice, J. Ethnopharmacol. 1999, 66 (2), 123-9.
56. Zhong Y.M., Nishigo H., Uwano T., Tamura R., Kawanishi K. and Ono T: Red ginseng ameliorated place navigation deficits in young rats with hippocampal lesions and aged rats, Physiol. Behav. 2000, 69(4-5), 511-25.
57. Sloley B.D., Pang P.K., Huang B.H., Ba F., Li F.L, Benishin C.G., Greenshaw A.J. and Shan J.J: American ginseng extract reduces scopolamine- induced amnesia in spatial learning task, J. Psychiatr Neurosci. 1999, 24 (5), 442-52.
58. McIntyre A: The Complete Floral Healer, Gaia Books Ltd., London 1996.
59. Perry N., Court G., Bidet N., Court J. and Perry E: European herbs with cholinergic activities: potential in dementia therapy, Int. J. Geriatric Psychiatry 1996, 11, 1063-1069.
60. Wren R.C: Potter's New Cyclopedia of Botanical Drugs and Preparations, The CW Daniel Company Ltd., Saffron Walden, 1985.
61. Miyazawa M., Watanabe H., Kameoka H: Inhibition of acetyl cholinesterase activity by monoterpenoids with a p-methane skeleton, J. Agric. Food Chem. 1997, 45, 677-679.
62. Mohamed A.F., Matsumoto K., Tabata K., Takayama H., Kitajima M. and Watanabe H: Effects of Uncaria tomentosa total alkaloid and its components on experimental amnesia in mice: elucidation using the passive avoidance test, J. Pharm. Pharmacology 2000, 52(12), 1553-61.
63. Higashida A. and Ogawa N: Differences in the acquisition process and the effect of scopolamine on radial maze performance on radial maze performance in the strains of rats, Pharmacol. Biochem. Behav. 1987, 27, 483-89.
64. Sitaram N., Weingartner H. and Gillin J.C: Human serial learning. Enhancement with arecholine and choline and impairment with scopolamine, Science 1978, 201, 247-76.